TMCnet News

Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
[January 02, 2014]

Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference


CAMBRIDGE, Mass. --(Business Wire)--

Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the Goldman Sachs Healthcare CEOs Unscripted Conference. The webcast will be live on Tuesday, January 7, 2014 at 4:00p.m. ET. To access the live webcast, please visit Biogen Idec's Investors section at

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.



[ Back To TMCnet.com's Homepage ]